MDxHealth (MDXH) Debt Ratio (2020 - 2026)

MDxHealth (MDXH) posted Debt Ratio of 0.82 for Q1 2026, up 18.41% sequentially from 0.69 in Q4 2025, and up 20.29% YoY from 0.68 in Q1 2025.

MDxHealth (MDXH) Debt Ratio (2020 - 2026) Analysis & Trends

MDxHealth has reported Debt Ratio for 7 years, with the latest figure at 0.82 in Q1 2026.

Quarterly Debt Ratio rose 20.29% year-over-year to 0.82 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.82 (up 20.29% YoY) and the FY2025 annual result came in at 0.69, up 159.69% from the prior year.
Debt Ratio climbed to 0.82 in Q1 2026 per MDXH's latest filing, from 0.69 in the prior quarter.
Over five years, Debt Ratio peaked at 616420.82 in Q2 2025 and troughed at 0.27 in Q4 2024.
A 5-year average of 41095.3 and a median of 0.68 in 2025 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2023 and 2025: Debt Ratio sank 62.23% in 2023, then soared 88096178.99% in 2025.
Over 5 years, Debt Ratio stood at 0.74 in 2022, then tumbled by 62.23% to 0.28 in 2023, then retreated by 5.31% to 0.27 in 2024, then soared by 159.69% to 0.69 in 2025, then advanced by 18.41% to 0.82 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.82, 0.69, and 0.66 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	0.40
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	0.30
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	0.03
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	0.26
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	0.54
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	0.24
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	0.22
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	0.58
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	0.32
10	MDxHealth	36.03 Mn	15.62 Mn	17.89 Mn	0.14

Download Data